Stem Cell Market

1. Executive Summary
    1.1. Key Market Insights  

2. Introduction            
    2.1. Study Objectives        
    2.2. Market Definition        
           2.2.1. Market Covered    
           2.2.2. Regional Coverage    
           2.2.3. Study Years & Currency    
    2.3. Market Stakeholders        
    2.4. Key Questions this Study will Answer        
    2.5. GMI Research’s Approach & Methodology  
           2.5.1. Research Data
           2.5.2. Primary Data
           2.5.3. Demand Side and Supply Side Analysis
           2.5.4. Market Size Estimation
           2.5.5. Research Assumptions

3. Global Stem Cell Market- Overview            
    3.1. Introduction         
    3.2. Market Segmentation        
    3.3. Value Chain Analysis        
    3.4. Market Drivers        
    3.5. Market Restraints        
    3.6. Market Trends      

4. Global Stem Cell Market Revenue Forecast till 2030     

5. Global Stem Cell Market by Product Revenue Forecast till 2030            
    5.1. Adult Stem Cells (ASCs)
    5.2. Hematopoietic
    5.3. Mesenchymal
    5.4. Neural
    5.5. Epithelial/Skin
    5.6. Others
    5.7. Human Embryonic Stem Cells
    5.8. Induced Pluripotent Stem Cells (Ipscs)
    5.9. Very Small Embryonic Like Stem Cells

6. Global Stem Cell Market by Application Revenue Forecast till 2030            
    6.1. Regenerative Medicine
    6.2. Drug Discovery and Development

7. Global Stem Cell Market by Technology Revenue Forecast till 2030            
    7.1. Cell Acquisition
    7.2. Cell Production
    7.3. Cryopreservation
    7.4. Expansion and Sub-Culture

8. Global Stem Cell Market by Region Forecast till 2030
    8.1. North America Stem Cell Market Revenue Forecast till 2030 
    (Option 1: As a part of the free 25% customization)
           8.1.1. North America Stem Cell Market by Product
                     8.1.1.1. Adult Stem Cells (ASCs)
                     8.1.1.2. Hematopoietic
                     8.1.1.3. Mesenchymal
                     8.1.1.4. Neural
                     8.1.1.5. Epithelial/Skin
                     8.1.1.6. Others
                     8.1.1.7. Human Embryonic Stem Cells
                     8.1.1.8. Induced Pluripotent Stem Cells (Ipscs)
                     8.1.1.9. Very Small Embryonic Like Stem Cells
           8.1.2. North America Stem Cell Market by Application
                     8.1.2.1. Regenerative Medicine
                     8.1.2.2. Drug Discovery and Development
           8.1.3. North America Stem Cell Market by Technology
                     8.1.3.1. Cell Acquisition
                     8.1.3.2. Cell Production
                     8.1.3.3. Cryopreservation
                     8.1.3.4. Expansion and Sub-Culture
           8.1.4. US Stem Cell Market All-Up
           8.1.5. Canada Stem Cell Market All-Up
    8.2. Europe Stem Cell Market Revenue Forecast till 2030 
    (Option 2: As a part of the free 25% customization)
           8.2.1. Europe Stem Cell Market by Product
                     8.2.1.1. Adult Stem Cells (ASCs)
                     8.2.1.2. Hematopoietic
                     8.2.1.3. Mesenchymal
                     8.2.1.4. Neural
                     8.2.1.5. Epithelial/Skin
                     8.2.1.6. Others
                     8.2.1.7. Human Embryonic Stem Cells
                     8.2.1.8. Induced Pluripotent Stem Cells (Ipscs)
                     8.2.1.9. Very Small Embryonic Like Stem Cells
           8.2.2. Europe Stem Cell Market by Application
                     8.2.2.1. Regenerative Medicine
                     8.2.2.2. Drug Discovery and Development
           8.2.3. Europe Stem Cell Market by Technology
                     8.2.3.1. Cell Acquisition
                     8.2.3.2. Cell Production
                     8.2.3.3. Cryopreservation
                     8.2.3.4. Expansion and Sub-Culture
           8.2.4. UK Stem Cell Market All-Up
           8.2.5. Germany Stem Cell Market All-Up
           8.2.6. France Stem Cell Market All-Up
           8.2.7. Spain Stem Cell Market All-Up
           8.2.8. Rest of Europe Stem Cell Market All-Up
    8.3. Asia-Pacific Stem Cell Market Revenue Forecast till 2030 
    (Option 3: As a part of the free 25% customization) 
           8.3.1. Asia-Pacific Stem Cell Market by Product
                     8.3.1.1. Adult Stem Cells (ASCs)
                     8.3.1.2. Hematopoietic
                     8.3.1.3. Mesenchymal
                     8.3.1.4. Neural
                     8.3.1.5. Epithelial/Skin
                     8.3.1.6. Others
                     8.3.1.7. Human Embryonic Stem Cells
                     8.3.1.8. Induced Pluripotent Stem Cells (Ipscs)
                     8.3.1.9. Very Small Embryonic Like Stem Cells
           8.3.2. Asia-Pacific Stem Cell Market by Application
                     8.3.2.1. Regenerative Medicine
                     8.3.2.2. Drug Discovery and Development
           8.3.3. Asia-Pacific Stem Cell Market by Technology
                     8.3.3.1. Cell Acquisition
                     8.3.3.2. Cell Production
                     8.3.3.3. Cryopreservation
                     8.3.3.4. Expansion and Sub-Culture
           8.3.4. China Stem Cell Market All-Up
           8.3.5. India Stem Cell Market All-Up
           8.3.6. Japan Stem Cell Market All-Up
           8.3.7. Rest of APAC Stem Cell Market All-Up
    8.4. RoW Stem Cell Market Revenue Forecast till 2030
    (Option 4: As a part of the free 25% customization)  
           8.4.1. RoW Stem Cell Market by Product
                     8.4.1.1. Adult Stem Cells (ASCs)
                     8.4.1.2. Hematopoietic
                     8.4.1.3. Mesenchymal
                     8.4.1.4. Neural
                     8.4.1.5. Epithelial/Skin
                     8.4.1.6. Others
                     8.4.1.7. Human Embryonic Stem Cells
                     8.4.1.8. Induced Pluripotent Stem Cells (Ipscs)
                     8.4.1.9. Very Small Embryonic Like Stem Cells
           8.4.2. RoW Stem Cell Market by Application
                     8.4.2.1. Regenerative Medicine
                     8.4.2.2. Drug Discovery and Development
           8.4.3. RoW Stem Cell Market by Technology
                     8.4.3.1. Cell Acquisition
                     8.4.3.2. Cell Production
                     8.4.3.3. Cryopreservation
                     8.4.3.4. Expansion and Sub-Culture
           8.4.4. Brazil Stem Cell Market All-Up
           8.4.5. South Africa Stem Cell Market All-Up
           8.4.6. Saudi Arabia Stem Cell Market All-Up
           8.4.7. UAE Stem Cell Market All-Up
           8.4.8. Rest of world (remaining countries of the LAMEA region) Stem Cell Market All-Up

9. Competitive Landscape Analysis
    9.1. Porter’s Five Forces Analysis
    9.2. Industry – Competitive Landscape
    9.3. Market Presence (Intensity Mapping)
    9.4. Key Strategic Market Developments 

10. Company Profiles (Option 5: Free 25% Customization - Profiles of 5 Additional Companies of your Choice)
    10.1. Advanced Cell Technology, Inc.
           10.1.1. Company Overview    
           10.1.2. Key Executives 
           10.1.3. Footprint & Employee Strength 
           10.1.4. Product Offerings    
           10.1.5. Financials
           10.1.6. Key Company Developments 
    10.2. STEMCELL Technologies, Inc.
           10.2.1. Company Overview    
           10.2.2. Key Executives   
           10.2.3. Footprint & Employee Strength
           10.2.4. Product Offerings
           10.2.5. Financials
           10.2.6. Key Company Developments
    10.3. BioTime, Inc.
           10.3.1. Company Overview    
           10.3.2. Key Executives
           10.3.3. Footprint & Employee Strength
           10.3.4. Product Offerings
           10.3.5. Financials
           10.3.6. Key Company Developments
    10.4. Cellular Engineering Technologies Inc.
           10.4.1. Company Overview    
           10.4.2. Key Executives
           10.4.3. Footprint & Employee Strength
           10.4.4. Product Offerings
           10.4.5. Financials
           10.4.6. Key Company Developments
    10.5. CellGenix GmbH
           10.5.1. Company Overview    
           10.5.2. Key Executives   
           10.5.3. Footprint & Employee Strength
           10.5.4. Product Offerings
           10.5.5. Financials
           10.5.6. Key Company Developments
    10.6. PromoCell GmbH
           10.6.1. Company Overview    
           10.6.2. Key Executives
           10.6.3. Footprint & Employee Strength
           10.6.4. Product Offerings
           10.6.5. Financials
           10.6.6. Key Company Developments
    10.7. Lonza
           10.7.1. Company Overview
           10.7.2. Key Executives
           10.7.3. Footprint & Employee Strength
           10.7.4. Product Offerings
           10.7.5. Financials
           10.7.6. Key Company Developments    
    10.8. Kite Pharma
           10.8.1. Company Overview
           10.8.2. Key Executives 
           10.8.3. Footprint & Employee Strength
           10.8.4. Product Offerings
           10.8.5. Financials
           10.8.6. Key Company Developments    
    10.9. Cellartis AB
           10.9.1. Company Overview
           10.9.2. Key Executives 
           10.9.3. Footprint & Employee Strength
           10.9.4. Product Offerings
           10.9.5. Financials
           10.9.6. Key Company Developments   
    10.10. Angel Biotechnology
           10.10.1. Company Overview
           10.10.2. Key Executives 
           10.10.3. Footprint & Employee Strength
           10.10.4. Product Offerings
           10.10.5. Financials
           10.10.6. Key Company Developments   

11. About GMI Research

*Details on Financials might not be available in case of unlisted/private companies.

*The list of companies is based on preliminary research in this sample report, the companies in the final report may change based on research findings.